awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51876606-3C596E92-B423-46CC-A568-567575BE5150
Q51876606-3C596E92-B423-46CC-A568-567575BE5150
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51876606-3C596E92-B423-46CC-A568-567575BE5150
Velcade combinations in mantle cell lymphoma: are we learning anything?
P2860
Q51876606-3C596E92-B423-46CC-A568-567575BE5150
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51876606-3C596E92-B423-46CC-A568-567575BE5150
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bec741e33480839fe39b295e9caa2464cfed1343
P2860
A phase II study of bortezomib and gemcitabine in relapsed mantle cell lymphoma from the National Cancer Institute of Canada Clinical Trials Group (IND 172).